tiprankstipranks
Trending News
More News >
Cannara Biotech (TSE:LOVE)
:LOVE
Canadian Market

Cannara Biotech (LOVE) Financial Statements

Compare
38 Followers

Cannara Biotech Financial Overview

Cannara Biotech's market cap is currently C$167.62M. The company's EPS TTM is C$0.01; its P/E ratio is 13.54; Cannara Biotech is scheduled to report earnings on January 26, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 107.32MC$ 81.75MC$ 57.26MC$ 35.84MC$ 17.02M
Gross ProfitC$ 47.22MC$ 29.79MC$ 27.23MC$ 17.33MC$ 10.30M
Operating IncomeC$ 22.20MC$ 10.08MC$ 11.89MC$ 3.67MC$ 192.60K
EBITDAC$ 28.18MC$ 15.16MC$ 15.77MC$ 9.54MC$ 3.22M
Net IncomeC$ 13.08MC$ 6.44MC$ 6.95MC$ 2.31MC$ -3.09M
Balance Sheet
Cash & Short-Term InvestmentsC$ 14.36MC$ 6.62MC$ 4.27MC$ 12.11MC$ 8.16M
Total AssetsC$ 168.65MC$ 154.72MC$ 141.52MC$ 125.62MC$ 92.02M
Total DebtC$ 41.58MC$ 48.33MC$ 45.78MC$ 48.39MC$ 20.90M
Net DebtC$ 27.22MC$ 41.71MC$ 41.51MC$ 36.28MC$ 12.74M
Total LiabilitiesC$ 66.43MC$ 66.77MC$ 61.78MC$ 58.88MC$ 27.91M
Stockholders' EquityC$ 102.22MC$ 87.95MC$ 79.74MC$ 66.74MC$ 64.12M
Cash Flow
Free Cash FlowC$ 13.65MC$ 3.21MC$ -4.44MC$ -21.55MC$ -33.17M
Operating Cash FlowC$ 20.01MC$ 10.68MC$ 5.44MC$ -6.08MC$ -2.09M
Investing Cash FlowC$ -5.95MC$ -5.19MC$ -9.48MC$ -15.35MC$ -30.83M
Financing Cash FlowC$ -6.32MC$ -3.14MC$ -3.72MC$ 25.46MC$ 33.25M
Currency in CAD

Cannara Biotech Earnings and Revenue History

Cannara Biotech Debt to Assets

Cannara Biotech Cash Flow

Cannara Biotech Forecast EPS vs Actual EPS